Botulinum Toxin A (Allergan, Inc, Irvine CA)

DRUG2 trials

Sponsors

Kaohsiung Veterans General Hospital., University of Massachusetts, Worcester

Conditions

Ankle OsteoarthritisHidradenitis Suppurativa (HS)

Phase 2

Botulinum Toxin Blockade of Neuronal Signals to Immune Cells as a Novel Treatment for Hidradenitis Suppurativa

Not yet recruitingNCT07756346

University of Massachusetts, WorcesterHidradenitis Suppurativa (HS)

Start: 2026-10-01End: 2029-04-01Target: 40Updated: 2026-09-10

Unknown Phase

Effects of Intraarticular Botulinum Toxin A in Ankle Osteoarthritis

CompletedNCT01760577

Kaohsiung Veterans General Hospital.Ankle Osteoarthritis

Start: 2010-05-31End: 2012-11-30Updated: 2013-01-04

Related Papers

Efficacy of intraarticular botulinum toxin A and intraarticular hyaluronate plus rehabilitation exercise in patients with unilateral ankle osteoarthritis: a randomized controlled trial

Journal of Foot and Ankle Research2014-01-0153 citations